Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Aug 7;57(10):936–940. doi: 10.1007/s13312-020-1998-0

Cardiac Involvement in Children With COVID-19

Utkarsh Kohli 1,, Rakesh Lodha 2
PMCID: PMC7605469  PMID: 32769232

Abstract

In contrast to adults, severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) usually leads to a mild illness in children. However, a few children have been reported to have severe manifestations including pneumonia, acute kidney injury, multi-organ failure and cardiac injury. This review focuses on cardiac involvement during SARS-CoV-2 infection and the recently described likely immune mediated post-COVID-19 syndrome. Therapeutic strategies for cardiac dysfunction in both these settings are briefly discussed.

Keywords: SARS-CoV-2, MIS-C, Myocarditis, Coronary dilation, Hypotension, Shock

References

  • 1.Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A Systematic Review [published online ahead of print, 2020 Apr 22]. JAMA Pediatr. 2020;10.1001/jamapediatrics.2020.1467. [DOI] [PubMed]
  • 2.Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088–95. doi: 10.1111/apa.15270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. A 55-day-old female infant infected with 2019 novel coronavirus disease: Presenting with pneumonia, liver injury, and heart damage. J Infect Dis. 2020;221:1775–81. doi: 10.1093/infdis/jiaa113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units [published online ahead of print, 2020 May 11]. JAMA Pediatr. 2020;10.1001/jamapediatrics.2020.1948. [DOI] [PMC free article] [PubMed]
  • 5.Gefen AM, Palumbo N, Nathan SK, Singer PS, Castellanos-Reyes LJ, Sethna CB. Pediatric COVID-19-associated rhabdomyolysis: A case report. Pediatr Nephrol. 2020;35:1517–20. doi: 10.1007/s00467-020-04617-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Available from: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed May 29, 2020
  • 7.World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed May 29, 2020
  • 8.Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247–50. doi: 10.1016/j.dsx.2020.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1–6. doi: 10.1001/jamacardio.2020.1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–10. doi: 10.1001/jamacardio.2020.0950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126:1443. doi: 10.1161/CIRCRESAHA.120.317055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Giacomet V, Manfredini VA, Meraviglia G, Peri CF, Sala A, Longoni E, et al. Acute inflammation and elevated cardiac markers in a two-month-old infant with severe acute respiratory syndrome coronavirus 2 infection presenting with cardiac symptoms. Pediatr Infect Dis J. 2020;39:e149–51. doi: 10.1097/INF.0000000000002750. [DOI] [PubMed] [Google Scholar]
  • 13.Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang F, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: A single centers observational study. World J Pediatr. 2020;16:251–9. doi: 10.1007/s12519-020-00354-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 2020;55:1169. doi: 10.1002/ppul.24718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. The different clinical characteristics of corona virus disease cases between children and their families in China — the character of children with COVID-19. Emerg Microbes Infect. 2020;9:707–13. doi: 10.1080/22221751.2020.1744483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Samuel S, Friedman RA, Sharma C, Ganigara M, Mitchell E, Schleien C, et al. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR positive SARS-CoV-2 infection including drug induced changes in the corrected QT interval (QTc) Heart Rhythm. 2020;S1547–5271:30632–9. doi: 10.1016/j.hrthm.2020.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Oberweis ML, Codreanu A, Boehm W, Olivier D, Pierron C, Tsobo C, et al. Pediatric Life-threatening coronavirus disease 2019 with myocarditis. Pediatr Infect Dis J. 2020;39:e147–e149. doi: 10.1097/INF.0000000000002744. [DOI] [PubMed] [Google Scholar]
  • 18.Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;e20200702. [DOI] [PubMed]
  • 19.Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020;179:1079–87. doi: 10.1007/s00431-020-03699-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome — temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children [published online ahead of print, 2020 Aug 6]. Indian Pediatr. 2020; S097475591600220. [DOI] [PMC free article] [PubMed]
  • 21.Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic [published online ahead of print, 2020 May 17]. Circulation. 2020;10.1161/CIRCULATIONAHA.120.048360. [DOI] [PubMed]
  • 22.Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–78. doi: 10.1016/S0140-6736(20)31103-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyper inflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8. doi: 10.1016/S0140-6736(20)31094-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem inflammatory syndrome in children during the COVID-19 pandemic: A case series. J Pediatric Infect Dis Soc. 2020;9:393–8. doi: 10.1093/jpids/piaa069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–46. doi: 10.1056/NEJMoa2021680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rawlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347–58. doi: 10.1056/NEJMoa2021756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [published online ahead of print, 2020 Jun 8]. JAMA. 2020;e2010369. [DOI] [PMC free article] [PubMed]
  • 28.American College of Rheumatology. Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Available from: https://www.rheumatology.org/Portals/0/Files/ACR-COVID-19-Clinical-Guidance-Summary-MIS-C-Hyperinflammation.pdf. Accessed August 7, 2020.
  • 29.Hassoun A, Thottacherry ED, Muklewicz J, Aziz QU, Edwards J. Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19. J Clin Virol. 2020;128:104443. doi: 10.1016/j.jcv.2020.104443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3. doi: 10.1007/s13312-020-1901-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES